Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centrica PLC Major Shareholding Notification 2025

Mar 24, 2025

5292_mrq_2025-03-24_361f31cf-4d7f-4073-8c3c-d95d7e34033a.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9226B

Centrica PLC

24 March 2025

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B033F229

Issuer Name

CENTRICA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name City of registered office Country of registered office
J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

20-Mar-2025

6. Date on which Issuer notified

24-Mar-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 3.045640 2.209589 5.255229 265021095
Position of previous notification (if applicable) 2.951481 2.346041 5.297522

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00B033F229 153591560 3.045640
Sub Total 8.A 153591560 3.045640%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Cash-settled Equity Swap 03/03/2026 03/03/2026 Cash 2444 0.000048
Cash-settled Equity Swap 19/11/2025 19/11/2025 Cash 173875 0.003448
Cash-settled Equity Swap 24/09/2025 24/09/2025 Cash 26520304 0.525884
Cash-settled Equity Swap 18/06/2025 18/06/2025 Cash 0 0.000000
Cash-settled Equity Swap 27/05/2027 27/05/2027 Cash 795817 0.015781
Cash-settled Equity Swap 18/05/2029 18/05/2029 Cash 2129605 0.042229
Cash-settled Equity Swap 18/02/2026 18/02/2026 Cash 103949 0.002061
Cash-settled Equity Swap 06/01/2026 06/01/2026 Cash 7784281 0.154358
Cash-settled Equity Swap 17/04/2026 17/04/2026 Cash 14300 0.000284
Cash-settled Equity Swap 29/10/2025 29/10/2025 Cash 27969 0.000555
Cash-settled Equity Swap 07/01/2026 07/01/2026 Cash 1250000 0.024787
Cash-settled Equity Swap 30/06/2025 30/06/2025 Cash 0 0.000000
Cash-settled Equity Swap 12/02/2026 12/02/2026 Cash 2707198 0.053682
Cash-settled Equity Swap 13/02/2026 13/02/2026 Cash 804382 0.015950
Cash-settled Equity Swap 17/06/2025 17/06/2025 Cash 0 0.000000
Cash-settled Equity Swap 27/03/2026 27/03/2026 Cash 6319 0.000125
Cash-settled Equity Swap 22/02/2027 22/02/2027 Cash 1678841 0.033291
Cash-settled Equity Swap 14/05/2025 14/05/2025 Cash 0 0.000000
Cash-settled Equity Swap 19/03/2026 19/03/2026 Cash 16851 0.000334
Cash-settled Equity Swap 09/09/2025 09/09/2025 Cash 67413400 1.336772
Sub Total 8.B2 111429535 2.209589%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co. J.P. Morgan Securities plc 5.162724%
JPMorgan Chase & Co. J.P. Morgan Securities LLC
JPMorgan Chase & Co. J.P. Morgan SE

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Chain of controlled undertakings:

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Securities plc (100%)

JPMorgan Chase & Co.

JPMorgan Chase Holdings LLC (100%)

J.P. Morgan Broker-Dealer Holdings Inc. (100%)

J.P. Morgan Securities LLC (100%)

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan SE (100%)

12. Date of Completion

24-Mar-2025

13. Place Of Completion

London, United Kingdom

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLSEMFLLEISEDD